ESR1 and ductal breast carcinoma in situ: The analysis of an independent set of breast lesions in the present study at both RNA and protein levels has revealed that benign lesions and DCIS may express NY-ESO and/or other CT genes (Table 1) but only DCIS expressed MAGEA was shown to be significantly associated with ER negativity.